Immunosuppression: a cause of porokeratosis?
Two patients are reported in which the development of porokeratosis occurred following chemotherapy for systemic malignancy. Immunosuppression associated with malignancy and chemotherapy may exacerbate or initiate the development of porokeratosis in patients predisposed to alterations of cutaneous growth dynamics.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003131:Combined Modality Therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007642:Keratosis / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000473:pathology; D013997:Time Factors